Halozyme Therapeutics, Inc. vs. Replimune Group, Inc.
Halozyme Therapeutics, Inc. and Replimune Group, Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| HALO | REPL | |
|---|---|---|
| Market Cap | $14.86 billion | $1.67 billion |
HALO leads on 1 of 1 size & scale factors.
Risk & Sentiment
| HALO | REPL | |
|---|---|---|
| Short Interest | 9.79% | 0.03% |
REPL leads on 1 of 1 risk & sentiment factors.
Dig deeper: HALO overview, HALO financials, REPL overview, REPL financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.